- $241.70m
- $667.05m
- $461.52m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 127 | 363 | 462 |
Cost of Revenue | |||||
Gross Profit | — | — | 1.25 | 33.1 | 3.67 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.01 | 3.5 | 216 | 494 | 582 |
Operating Profit | -0.01 | -3.5 | -88.1 | -131 | -120 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.01 | -113 | -101 | -139 | -140 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.01 | -113 | -101 | -124 | -140 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.01 | -113 | -101 | -124 | -140 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.01 | -113 | -101 | -124 | -140 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -2.36 | -0.867 | -0.771 | -1.12 |
Dividends per Share |